Containers For Compositions Comprising Meloxicam

Patent No. EP2488145 (titled "Containers For Compositions Comprising Meloxicam") was filed by Boehringer Ingelheim on Oct 11, 2010. The application was issued on Apr 24, 2024.

Patent Summary

A plastic container for storing and preserving a pharmaceutical composition comprising sodium benzoate and meloxicam (or a pharmaceutically acceptable salt thereof) is disclosed. The container material consists of a polypropylene (PP) homopolymer, a PP copolymer, and optionally one or more non-polymeric components. The container has a volume of 3 ml to 11 ml (preferably 3 ml to 10 ml, 3 ml to 8 ml, 3 ml to 5 ml, 3.5 ml to 4.5 ml, or 3 ml to 4 ml). The pharmaceutical composition contained therein has a volume of 2 ml to 10 ml (preferably 2.5 ml to 8 ml, 2.5 ml to 5 ml, 3.5 ml to 4.5 ml, or 3 ml to 4.5 ml). The PP material prevents significant sodium benzoate loss via adsorption, ensuring stability for at least 18 months.

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
VIRBACApr 25, 2024AXE PI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2488145

BOEHRINGER INGELHEIM
Application Number
EP10771837A
Filing Date
Oct 11, 2010
Status
Granted And Under Opposition
Mar 22, 2024
Publication Date
Apr 24, 2024